Endurant Capital Management’s Ocera Therapeutics, Inc. OCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-120,942
| Closed | -$140K | – | 108 |
|
|
2017
Q2 | $140K | Sell |
120,942
-31,700
| -21% | -$36.7K | 0.04% | 92 |
|
|
2017
Q1 | $200K | Sell |
152,642
-73,800
| -33% | -$96.7K | 0.06% | 88 |
|
|
2016
Q4 | $476K | Buy |
226,442
+123,300
| +120% | +$259K | 0.2% | 63 |
|
|
2016
Q3 | $272K | Hold |
103,142
| – | – | 0.1% | 92 |
|
|
2016
Q2 | $196K | Sell |
103,142
-33,951
| -25% | -$64.5K | 0.07% | 87 |
|
|
2016
Q1 | $403K | Hold |
137,093
| – | – | 0.13% | 75 |
|
|
2015
Q4 | $428K | Sell |
137,093
-40,028
| -23% | -$125K | 0.14% | 72 |
|
|
2015
Q3 | $560K | Sell |
177,121
-54,020
| -23% | -$171K | 0.19% | 66 |
|
|
2015
Q2 | $878K | Buy |
231,141
+71,939
| +45% | +$273K | 0.26% | 67 |
|
|
2015
Q1 | $750K | Sell |
159,202
-51,077
| -24% | -$241K | 0.25% | 77 |
|
|
2014
Q4 | $1.34M | Buy |
+210,279
| New | +$1.34M | 0.53% | 52 |
|